These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 8408569)
1. Reactogenicity and immunogenicity of a high-titer rhesus rotavirus-based quadrivalent rotavirus vaccine. Flores J; Perez-Schael I; Blanco M; Rojas AM; Alfonzo E; Crespo I; Cunto W; Pittman AL; Kapikian AZ J Clin Microbiol; 1993 Sep; 31(9):2439-45. PubMed ID: 8408569 [TBL] [Abstract][Full Text] [Related]
2. Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants. Perez-Schael I; Blanco M; Vilar M; Garcia D; White L; Gonzalez R; Kapikian AZ; Flores J J Clin Microbiol; 1990 Mar; 28(3):553-8. PubMed ID: 2157737 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the antigenicity and reactogenicity of varying formulations of the rhesus rotavirus-based quadrivalent and the M37 rotavirus vaccine candidates. Perez-Schael I; Blanco M; Garcia D; White L; Alfonzo E; Crespo I; Cunto W; Pittman AL; Kapikian AZ; Flores J J Med Virol; 1994 Apr; 42(4):330-7. PubMed ID: 8046423 [TBL] [Abstract][Full Text] [Related]
4. Reactions to and antigenicity of two human-rhesus rotavirus reassortant vaccine candidates of serotypes 1 and 2 in Venezuelan infants. Flores J; Perez-Schael I; Blanco M; Vilar M; Garcia D; Perez M; Daoud N; Midthun K; Kapikian AZ J Clin Microbiol; 1989 Mar; 27(3):512-8. PubMed ID: 2541168 [TBL] [Abstract][Full Text] [Related]
5. Comparison of reactogenicity and antigenicity of M37 rotavirus vaccine and rhesus-rotavirus-based quadrivalent vaccine. Flores J; Perez-Schael I; Blanco M; White L; Garcia D; Vilar M; Cunto W; Gonzalez R; Urbina C; Boher J Lancet; 1990 Aug; 336(8711):330-4. PubMed ID: 1975333 [TBL] [Abstract][Full Text] [Related]
6. Comparative evaluation of reactogenicity and immunogenicity of two dosages of oral tetravalent rhesus rotavirus vaccine. US Rhesus Rotavirus Vaccine Study Group. Dennehy PH; Rodgers GC; Ward RL; Markwick AJ; Mack M; Zito ET Pediatr Infect Dis J; 1996 Nov; 15(11):1012-8. PubMed ID: 8933551 [TBL] [Abstract][Full Text] [Related]
7. Effect of dose and a comparison of measures of vaccine take for oral rhesus rotavirus vaccine. The Maryland Clinical Studies Group. Pichichero ME; Losonsky GA; Rennels MB; Disney FA; Green JL; Francis AB; Marsocci SM Pediatr Infect Dis J; 1990 May; 9(5):339-44. PubMed ID: 2162027 [TBL] [Abstract][Full Text] [Related]
8. Comparison of immunogenicity and efficacy of rhesus rotavirus reassortant vaccines in breastfed and nonbreastfed children. US Rotavirus Vaccine Efficacy Group. Rennels MB; Wasserman SS; Glass RI; Keane VA Pediatrics; 1995 Dec; 96(6):1132-6. PubMed ID: 7491235 [TBL] [Abstract][Full Text] [Related]
10. Simultaneous administration of rhesus rotavirus vaccine and oral poliovirus vaccine: immunogenicity and reactogenicity. Ho MS; Floyd RL; Glass RI; Pallansch MA; Jones B; Hamby B; Woods P; Penaranda ME; Kapikian AZ; Bohan G Pediatr Infect Dis J; 1989 Oct; 8(10):692-6. PubMed ID: 2554244 [TBL] [Abstract][Full Text] [Related]
11. Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity. Vesikari T; Ruuska T; Green KY; Flores J; Kapikian AZ Pediatr Infect Dis J; 1992 Jul; 11(7):535-42. PubMed ID: 1326741 [TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and safety of rhesus-human rotavirus reassortant vaccines with serotype 1 or 2 VP7 specificity. Vesikari T; Varis T; Green K; Flores J; Kapikian AZ Vaccine; 1991 May; 9(5):334-9. PubMed ID: 1651610 [TBL] [Abstract][Full Text] [Related]
13. Reactogenicity and antigenicity of rhesus rotavirus vaccine (MMU-18006) in newborn infants in Venezuela. Flores J; Daoud G; Daoud N; Puig M; Martinez M; Perez-Schael I; Shaw R; Greenberg HB; Midthun K; Kapikian AZ Pediatr Infect Dis J; 1988 Nov; 7(11):776-80. PubMed ID: 2852792 [TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and reactogenicity of rhesus rotavirus vaccine given in combination with oral or inactivated poliovirus vaccines and diphtheria-tetanus-pertussis vaccine. Jalil F; Zaman S; Carlsson B; Glass RI; Kapikian AZ; Mellander L; Hanson LA Trans R Soc Trop Med Hyg; 1991; 85(2):292-6. PubMed ID: 1653474 [TBL] [Abstract][Full Text] [Related]
15. Immunogenicity, safety and protective efficacy of one dose of the rhesus rotavirus vaccine and serotype 1 and 2 human-rhesus rotavirus reassortants in children from Lima, Peru. Lanata CF; Black RE; Flores J; Lazo F; Butron B; Linares A; Huapaya A; Ventura G; Gil A; Kapikian AZ Vaccine; 1996 Feb; 14(3):237-43. PubMed ID: 8920706 [TBL] [Abstract][Full Text] [Related]
16. Symptoms associated with rhesus-human reassortant rotavirus vaccine in infants. Joensuu J; Koskenniemi E; Vesikari T Pediatr Infect Dis J; 1998 Apr; 17(4):334-40. PubMed ID: 9576390 [TBL] [Abstract][Full Text] [Related]
17. A comparative trial of rhesus monkey (RRV-1) and bovine (RIT 4237) oral rotavirus vaccines in young children. Vesikari T; Kapikian AZ; Delem A; Zissis G J Infect Dis; 1986 May; 153(5):832-9. PubMed ID: 3009634 [TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of tetravalent rhesus rotavirus vaccine administered with buffer and oral polio vaccine. Ing DJ; Glass RI; Woods PA; Simonetti M; Pallansch MA; Wilcox WD; Davidson BL; Sievert AJ Am J Dis Child; 1991 Aug; 145(8):892-7. PubMed ID: 1650128 [TBL] [Abstract][Full Text] [Related]